Back
Sutro Biopharma, Inc. 10K Form
Sell
21
STRO
Sutro Biopharma, Inc.
Last Price:
$10.00
Seasonality Move:
-18.96%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-06 | 10Q | STRO/Sutro Biopharma, Inc. Quarterly |
| 2020-05-11 | 10Q | STRO/Sutro Biopharma, Inc. Quarterly |
| 2020-05-04 | 10K | STRO/Sutro Biopharma, Inc. Annual |
| 2020-03-16 | 10K | STRO/Sutro Biopharma, Inc. Annual |
| 2019-11-08 | 10Q | STRO/Sutro Biopharma, Inc. Quarterly |
| 2019-08-14 | 10Q | STRO/Sutro Biopharma, Inc. Quarterly |
Receive STRO News And Ratings
See the #1 stock for the next 7 days that we like better than STRO
STRO Financial Statistics
Sales & Book Value
| Annual Sales: | $62M |
|---|---|
| Cash Flow: | $-38.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-10.25 |
| Price / Book: | 1.64 |
Profitability
| EPS (TTM): | -17.75110 |
|---|---|
| Net Income (TTM): | $-216.8M |
| Gross Margin: | $54.8M |
| Return on Equity: | -10195.04% |
| Return on Assets: | -66.39% |
Sutro Biopharma, Inc. Earnings Forecast
Key Sutro Biopharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 9 years for STRO is 88.37%.
-
The Selling, General & Administrative Expenses for STRO have been equal to 78.10% of Gross Profit Margin.
-
The Research & Development expenses have been 406.24% of Revenue.
-
The Net Earning history of STRO is -366.62% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 3 years.
Sutro Biopharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | STRO |
| CUSIP: | 869367 |
| Website: | sutrobio.com |
Debt
| Debt-to-Equity Ratio: | -2.61 |
|---|---|
| Current Ratio: | 2.53 |
| Quick Ratio: | 2.39 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
STRO Technical Analysis vs Fundamental Analysis
Sell
21
Sutro Biopharma, Inc. (STRO)
is a Sell
Is Sutro Biopharma, Inc. a Buy or a Sell?
-
Sutro Biopharma, Inc. stock is rated a SellThe current Sutro Biopharma, Inc. [STRO] share price is $8.93. The Score for STRO is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.